glp 1 anesthesia ASA Advises No Longer Holding GLP-1 Agents Prior to Surgery for Most Patients AAOMS may update anesthesia guide

GLP-1 signals fullness, prompts insulin from the pancreas, and slows stomach emptying

The cagrilintide + tirzepatide stack is a two-compound research protocol that combines an FDA-approved obesity drug with an investigational fullness peptide

Stenmark et al., 2021)

Retatrutide simultaneously activates GLP-1, GIP, and glucagon receptors, creating synergistic effects that enhance insulin secretion, suppress appetite, slow gastric emptying, and increase energy expenditure

The grueling nature of a diet and exercise plan can deplete motivation

The mechanism of action for LDN is that it temporarily blocks opioid receptors in the Central Nervous System (CNS)